Topical Collagen-Based Biomaterials for Chronic Wounds: Rationale and Clinical Application.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26858912)

Published in Adv Wound Care (New Rochelle) on January 01, 2016

Authors

Lisa J Gould1

Author Affiliations

1: Wound Recovery and Hyperbaric Medicine Center , Kent Hospital, Warwick, Rhode Island.

Articles cited by this

Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer (2003) 6.65

An overview of tissue and whole organ decellularization processes. Biomaterials (2011) 4.78

Collagen structure and stability. Annu Rev Biochem (2009) 4.62

The extracellular matrix as a biologic scaffold material. Biomaterials (2007) 3.18

Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen (2009) 2.83

Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A (1997) 2.37

Collagen--biomaterial for drug delivery. Eur J Pharm Biopharm (1998) 2.04

Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol (2003) 1.99

Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen (2002) 1.68

Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care (2005) 1.65

Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: a systematic review. Ann Intern Med (2013) 1.62

New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci (2002) 1.58

Scarless fetal wound healing: a basic science review. Plast Reconstr Surg (2010) 1.56

Designing regenerative biomaterial therapies for the clinic. Sci Transl Med (2012) 1.47

Epithelialization in Wound Healing: A Comprehensive Review. Adv Wound Care (New Rochelle) (2014) 1.45

Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium (2004) 1.43

Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng (2006) 1.40

Dystrophic epidermolysis bullosa: pathogenesis and clinical features. Dermatol Clin (2010) 1.39

An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss. Sci Transl Med (2014) 1.38

Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem (2002) 1.36

Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg (2005) 1.36

Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem (2008) 1.29

Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J Tissue Eng Regen Med (2008) 1.29

Collagen in the scarless fetal skin wound: detection with picrosirius-polarization. Wound Repair Regen (2005) 1.29

Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev (2003) 1.25

A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg (2002) 1.21

Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. Cells Tissues Organs (2011) 1.19

Wound Care Outcomes and Associated Cost Among Patients Treated in US Outpatient Wound Centers: Data From the US Wound Registry. Wounds (2012) 1.18

Surgicel: its fate following implantation. J Oral Pathol (1984) 1.16

Antimicrobial activity associated with extracellular matrices. Tissue Eng (2002) 1.15

Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control. Arch Surg (2003) 1.14

Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol (2002) 1.14

Biomaterials and bioengineering tomorrow's healthcare. Biomatter (2013) 1.12

Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study. Orthopedics (2004) 1.08

Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell Mol Med (2008) 1.08

Hybrid nanofibrous scaffolds from electrospinning of a synthetic biodegradable elastomer and urinary bladder matrix. J Biomater Sci Polym Ed (2008) 1.07

The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol (2002) 1.06

Development of collagenase-resistant collagen and its interaction with adult human dermal fibroblasts. Biomaterials (2003) 1.02

Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg (2002) 1.00

The effect of source animal age upon the in vivo remodeling characteristics of an extracellular matrix scaffold. Biomaterials (2012) 1.00

Collagen VII plays a dual role in wound healing. J Clin Invest (2013) 1.00

The retention of extracellular matrix proteins and angiogenic and mitogenic cytokines in a decellularized porcine dermis. Biomaterials (2010) 1.00

The structure of type IV collagen. Ann N Y Acad Sci (1985) 0.99

Nanofibrous structured biomimetic strategies for skin tissue regeneration. Wound Repair Regen (2012) 0.99

Type I collagen D-spacing in fibril bundles of dermis, tendon, and bone: bridging between nano- and micro-level tissue hierarchy. ACS Nano (2012) 0.99

Clinical and cost efficacy of advanced wound care matrices for venous ulcers. J Manag Care Pharm (2012) 0.98

The effect of source animal age upon extracellular matrix scaffold properties. Biomaterials (2010) 0.97

Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J (2009) 0.97

The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J (2006) 0.97

A review of fetal scarless healing. ISRN Dermatol (2012) 0.96

Proteases and Delayed Wound Healing. Adv Wound Care (New Rochelle) (2013) 0.95

Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol (2000) 0.94

Understanding roles of porcine small intestinal submucosa in urinary bladder regeneration: identification of variable regenerative characteristics of small intestinal submucosa. Tissue Eng Part B Rev (2013) 0.94

Towards scalable production of a collagen-like protein from Streptococcus pyogenes for biomedical applications. Microb Cell Fact (2012) 0.93

Review collagen-based biomaterials for wound healing. Biopolymers (2014) 0.93

Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers. Adv Wound Care (1998) 0.93

Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology. Adv Skin Wound Care (2010) 0.91

Matricryptins and matrikines: biologically active fragments of the extracellular matrix. Exp Dermatol (2014) 0.90

Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res (2009) 0.90

Collagen IV in Normal Skin and in Pathological Processes. N Am J Med Sci (2012) 0.90

Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice. J Biomed Mater Res (1997) 0.90

The healing properties of Promogran in venous leg ulcers. J Wound Care (2002) 0.89

Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure. Mol Ther (2013) 0.89

In vivo degradation of oxidized, regenerated cellulose. Carbohydr Res (1990) 0.88

Impaired biomechanical properties of diabetic skin implications in pathogenesis of diabetic wound complications. Am J Pathol (2011) 0.87

Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials (2005) 0.87

Comparative study of bovine, porcine and avian collagens for the production of a tissue engineered dermis. Acta Biomater (2011) 0.87

Functional characterization of detergent-decellularized equine tendon extracellular matrix for tissue engineering applications. PLoS One (2013) 0.87

Effect of oxidized regenerated cellulose/collagen matrix on proteases in wound exudate of patients with diabetic foot ulcers. J Wound Ostomy Continence Nurs (2011) 0.87

Surface modification of nanofibrous polycaprolactone/gelatin composite scaffold by collagen type I grafting for skin tissue engineering. Mater Sci Eng C Mater Biol Appl (2013) 0.87

Evaluation of small intestine grafts decellularization methods for corneal tissue engineering. PLoS One (2013) 0.86

Effect of the sterilization method on the performance of collagen type I on chronic wound parameters in vitro. J Biomed Mater Res B Appl Biomater (2009) 0.85

Biochemical and biomechanical characterization of porcine small intestinal submucosa (SIS): a mini review. Int J Burns Trauma (2013) 0.85

Cellular versus acellular matrix devices in treatment of diabetic foot ulcers: study protocol for a comparative efficacy randomized controlled trial. Trials (2013) 0.84

Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment. Wound Repair Regen (2013) 0.84

The role of oxidised regenerated cellulose/collagen in wound repair: effects in vitro on fibroblast biology and in vivo in a model of compromised healing. Int J Biochem Cell Biol (2002) 0.83

Interactions of the Extracellular Matrix and Progenitor Cells in Cutaneous Wound Healing. Adv Wound Care (New Rochelle) (2013) 0.81

A functional extracellular matrix biomaterial derived from ovine forestomach. Biomaterials (2010) 0.81

Rescue of migratory defects of Ehlers-Danlos syndrome fibroblasts in vitro by type V collagen but not insulin-like binding protein-1. J Invest Dermatol (2008) 0.81

Electrospun Tropoelastin for Delivery of Therapeutic Adipose-Derived Stem Cells to Full-Thickness Dermal Wounds. Adv Wound Care (New Rochelle) (2014) 0.81

Targeting Inflammatory Cytokines and Extracellular Matrix Composition to Promote Wound Regeneration. Adv Wound Care (New Rochelle) (2014) 0.81

A prospective comparison of diabetic foot ulcers treated with either a cryopreserved skin allograft or a bioengineered skin substitute. Wounds (2011) 0.80

OASIS wound matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J (2007) 0.80

Cutaneous wound healing after treatment with plant-derived human recombinant collagen flowable gel. Tissue Eng Part A (2013) 0.80

Extracellular matrix modulates angiogenesis in physiological and pathological conditions. Biomed Res Int (2014) 0.80

In vivo degradation of 14C-labeled porcine dermis biologic scaffold. Biomaterials (2014) 0.80

Comparative effectiveness of advanced wound dressings for patients with chronic venous leg ulcers: a systematic review. Wound Repair Regen (2014) 0.79

Type V collagen in experimental granulation tissue. Connect Tissue Res (1998) 0.78

Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review. Diabetes Metab Syndr Obes (2013) 0.78

Three types of dermal grafts in rats: the importance of mechanical property and structural design. Biomed Eng Online (2013) 0.77

A systematic review of randomized controlled trials of wound dressings for chronic venous ulcer. J Vasc Surg (2006) 0.77

Recombinant human collagen III gel for transplantation of autologous skin cells in porcine full-thickness wounds. J Tissue Eng Regen Med (2013) 0.77

Cloning of cDNA for rat pro alpha1(V) collagen mRNA. Expression patterns of type I, type III and type V collagen genes in experimental granulation tissue. Connect Tissue Res (1999) 0.76

Fish scale collagen sponge incorporated with Macrotyloma uniflorum plant extract as a possible wound/burn dressing material. Colloids Surf B Biointerfaces (2013) 0.76

Tissue extracellular matrix nanoparticle presentation in electrospun nanofibers. Biomed Res Int (2014) 0.76

Wound repair capability in EDS fibroblasts can be retrieved by exogenous type V collagen. ScientificWorldJournal (2008) 0.75